237 related articles for article (PubMed ID: 18095036)
1. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.
Goldstein NE; Mehta D; Teitelbaum E; Bradley EH; Morrison RS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):2-6. PubMed ID: 18095036
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
[TBL] [Abstract][Full Text] [Related]
3. Improving Communication in Heart Failure Patient Care.
Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
[TBL] [Abstract][Full Text] [Related]
4. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.
Goldstein NE; Mehta D; Siddiqui S; Teitelbaum E; Zeidman J; Singson M; Pe E; Bradley EH; Morrison RS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):7-12. PubMed ID: 18095037
[TBL] [Abstract][Full Text] [Related]
5. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
[TBL] [Abstract][Full Text] [Related]
6. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with ICDs at the end of life (EOL): a qualitative study.
Kelley AS; Mehta SS; Reid MC
Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
[TBL] [Abstract][Full Text] [Related]
9. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
Kramer DB; Kesselheim AS; Brock DW; Maisel WH
Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
[TBL] [Abstract][Full Text] [Related]
10. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
[TBL] [Abstract][Full Text] [Related]
11. Quality dying: An approach to ICD deactivation in the hospital setting.
Turner S; Torabi S; Stilos K
Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
[TBL] [Abstract][Full Text] [Related]
12. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
Brady DR
Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
[TBL] [Abstract][Full Text] [Related]
13. Clinician Attitudes Regarding ICD Deactivation in DNR/DNI Patients.
Bradley A; Marks A
J Hosp Med; 2017 Jul; 12(7):498-502. PubMed ID: 28699936
[TBL] [Abstract][Full Text] [Related]
14. Implantable Cardiac Defibrillator Deactivation During End-of-Life Care in the COVID-19 Pandemic.
Myers SE; Eastwood GL
J Am Board Fam Med; 2021; 34(3):474-476. PubMed ID: 34088806
[TBL] [Abstract][Full Text] [Related]
15. The doctor's role in discussing advance preferences for end-of-life care: perceptions of physicians practicing in the VA.
Markson L; Clark J; Glantz L; Lamberton V; Kern D; Stollerman G
J Am Geriatr Soc; 1997 Apr; 45(4):399-406. PubMed ID: 9100706
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Novel Educational Intervention to Improve Conversations About Implantable Cardioverter-Defibrillators Management in Patients with Advanced Heart Failure.
Kwok IB; Mather H; McKendrick K; Gelfman L; Hutchinson MD; Lampert RJ; Lipman HI; Matlock DD; Swetz KM; Kalman J; Pinney S; Morrison RS; Goldstein NE
J Palliat Med; 2020 Dec; 23(12):1619-1625. PubMed ID: 32609036
[No Abstract] [Full Text] [Related]
17. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
18. Discussing end-of-life care or what do we know?
Bartlow B
Nephrol News Issues; 2005 Mar; 19(4):55-6, 66. PubMed ID: 15813318
[No Abstract] [Full Text] [Related]
19. 'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.
Standing H; Thomson RG; Flynn D; Hughes J; Joyce K; Lobban T; Lord S; Matlock DD; McComb JM; Paes P; Wilkinson C; Exley C
BMJ Open; 2021 Jul; 11(7):e048024. PubMed ID: 34230020
[TBL] [Abstract][Full Text] [Related]
20. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Waterhouse E; Ahmad F
Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
